Background. This study aimed to detect if intrathecal (i.t.) ropivacaine and levobupivacaine provided anaesthesia (satisfactory analgesia and muscular relaxation) and postoperative analgesia of similar quality to bupivacaine in patients undergoing Caesarean section.
New expensive long-acting local anaesthetics (ropivacaine, levobupivacaine) have recently been introduced for clinical use. The claimed bene®ts of these are reduced cardiac toxicity on overdose and more speci®c effects on sensory rather than motor nerve ®bres. 1±4 These advantages do not appear clinically signi®cant when single shot spinal anaesthesia is considered. The prospective study described in this paper was therefore designed to determine if these drugs offered any other advantage over bupivacaine in Caesarean section. The quality of anaesthesia and postoperative residual analgesia of ropivacaine and levobupivacaine were therefore compared with bupivacaine, and the duration of motor block. Sufentanil was added to the local anaesthetic solutions. This was done not solely because such combinations have usually been associated with improved anaesthesia and analgesia but because it also allows the use of very low doses of local anaesthetic enabling the detection of subtle potency differences. 5 6 
Methods
The protocol was approved by the Clinical Research Practices Committee, and written informed consent was obtained from each patient. Ninety ASA I±II parturients undergoing elective Caesarean section were enrolled in the study. Uncomplicated pregnancy and normal fetal heart rate at the time of admission and randomization were mandatory inclusion criteria. All patients received ranitidine 150 mg orally the night before and on the morning of surgery. Sodium citrate, 30 ml orally, was administered at the time of arrival into the operating room.
Before the study, patients were instructed on the method of sensory and motor assessments, and baseline measurements were performed. All parturients received oxygen ( lateral position. To perform a needle through needle technique, an 8-cm 16-gauge Tuohy needle (Portex Ltd, Hythe, Kent, UK) was inserted into the epidural space at the L3±L4 interspace by a loss-of-resistance technique. The dura was punctured using a 29-gauge pencil-point needle (Becton-Dickinson, NJ, USA) oriented with the ori®ce facing cephalad. The study solution was injected and a multi-ori®ce epidural catheter was inserted 3 cm into the epidural space. As determined by a table of random numbers, patients received one of the following glucosefree intrathecal (i.t.) solutions: ropivacaine 12 mg (Group Ropi 12), bupivacaine 8 mg (Group Bupi 8), and levobupivacaine 8 mg (Group Levo 8). In each group, sufentanil 2.5 mg was added to the local anaesthetic. Based on previous studies by our group, 7 8 sample size was determined at 30 patients per group. To facilitate blinding, the study drugs were diluted to 3.0 ml with normal saline and prepared by an anaesthetist not involved with subsequent patient assessments. After con®rming free¯ow of cerebrospinal¯uid, spinal solutions were injected over approximately 60 s.
The patients were placed supine with a left lateral tilt and a pillow under the thigh. Arterial pressure and heart rate were monitored using a non-invasive monitor (Cardiocap Datex, Helsinki, Finland) every 2 min until delivery then every 5 min during the rest of the procedure and the two ®rst postoperative hours. I.V. ephedrine 5 mg was given concomitantly with the i.t. injection in order to prevent hypotension. 9 After 20 min, surgery was allowed to start if the upper dermatome level of loss of discrimination to pinprick was at or above T4. This time was noted as the onset of sensory block. Sensory changes were recorded bilaterally along the midclavicular line by assessing changes in pinprick sensation using a 25-gauge needle protruding 2 mm through a guard. This measurement was performed before i.t. injection, then every 2 min from 6 to 20 min and then every 10 min until recovery to T12.
Motor block was assessed by the investigators using a modi®ed Bromage scale (1=complete motor block; 2=al-most complete motor blockÐthe patient is able to move the feet only; 3=partial motor blockÐthe patient is able to move the knees; 4=detectable weakness of hip¯exionÐthe patient is able to raise the leg but unable to keep it raised; 5=no detectable weakness of hip¯exionÐthe patient is able to keep the leg raised for 10 s or more; 6=no weakness at allÐthe patient is able to perform partial knee bend while supine). This test was performed at baseline, then 10, 15, and 20 min after i.t. injection and as soon as possible at the end of surgery. After surgery it was performed every 15 min. During the procedure, the surgeons evaluated muscle relaxation according to a four-point scale (1=excellent, 2=good, 3=fair, 4=poor).
Pain was assessed with a 10-cm linear visual analogue scale (VAS) at incision, birth and peritoneal closure and at 15 min intervals after surgery. Before anaesthesia, parturients were instructed that fetal extraction might be associated with some degree of discomfort. In the case of unbearable discomfort (score of 5 or greater on a 10-point numerical score or maternal request for rescue), 10 ml of lidocaine 2% plus epinephrine 1/200 000 were injected epidurally. Rescue epidural analgesic administration was considered indicative of a failure of the i.t. technique. Consequently, subsequent data concerning pain, sensory and motor block were not taken into account. In these patients, however, data for the onset of spinal anaesthesia before epidural top-up were included for analysis.
For assessment of the onset of anaesthesia, the time for sensory block to develop to maximum block height and the time to achieve maximum Bromage score were recorded. To assess the duration of the sensory block, the two-segment regression time from the maximum block height and time for regression to T10 were used. Duration of motor block was assessed by recording the time elapsed from the maximum to the lowest Bromage score. The duration of analgesia provided by the i.t. solutions was taken as the time elapsed between i.t. injection and the ®rst additional analgesic request.
Immediately after surgery, parturients were questioned about the quality of their anaesthesia using a four-point scale (1=perfect, 2=some feelings but no discomfort, 3=some discomfort but rescue analgesia unnecessary, 4=major discomfort and rescue analgesia mandatory). The incidence of side effects such as nausea, vomiting, hypotension (de®ned by a drop in systolic arterial pressure below 100 mm Hg or less than 80% of the baseline), and pruritus were noted. All parturients were examined for transient radicular irritation syndrome on days 1 and 3 and after 1 month.
Statistical analysis
Comparison of the primary variable, namely the success rate in the different groups, was assessed by the Fisher's Exact test using subsequently the superiority approach and the non-inferiority method. 10 In the superiority approach, the null hypothesis implies that the success rate in the groups which are being compared is equal. In case the null hypothesis has to be rejected after the statistical test (P<0.05) it is concluded that one of the groups is superior to the others in terms of success rate. In case of the noninferiority approach, the null hypothesis states that one (11) 58 (13) 57 (13) group is inferior to the other. When this null hypothesis is rejected (P<0.05) then the alternative hypothesis, namely that the groups are not inferior to each other, becomes more probable. Another way of describing non-inferiority is that one treatment`is not worse than the other'. In the noninferiority approach, clinical relevance is expressed by means of the 97.5% upper con®dence level (CL). The maximum allowed difference of 20% is considered as a clinically relevant boundary.
Values below 20% indicate non-inferiority. The exact power of tests for non-inferiority of two binomial populations with a maximum allowable difference of 20%, type I error (alpha) of 0.025, probabilities of no response in the two study groups of 87 and 80%, respectively, and 30 patients in each study group is 79.2%.
Statistical analysis for the primary variable was carried out by the software package PROC STATXACT version 5 for SAS users (Statistical Software for Exact Nonparametric Inference (February 2002), CYTEL Software Corporation, Cambridge, MA, ISBN).
For the secondary variables, the following methods were applied: continuous variables among groups were compared by one-way analysis of variance (ANOVA) followed by Student's Newman±Keuls tests for multiple comparisons. Nominal categorical data among study groups were com- 
Results
Treatment groups did not differ with respect to patient characteristics ( Table 1 ). The outcome of anaesthesia is summarized in Table 2 Table 3 . The most notable difference is the longer duration of motor block in the bupivacaine group (P`0.05). The time to ®rst analgesic request was also signi®cantly greater in this group.
When considering the parturients' evaluation of analgesia (scores of quality and VAS), no signi®cant difference was noted. The incidence of hypotension, consumption of ephedrine, and episodes of nausea and vomiting were similar. Delivery was uneventful in all parturients. No patients presented with either transient radicular irritation syndrome or back pain when examined at the postoperative visit.
Discussion
Our results clearly show that the racemic mixture bupivacaine 8 mg associated with sufentanil 2.5 mg remains an adequate choice for Caesarean section under spinal anaesthesia. The success rate is signi®cantly superior to levobupivacaine 8 mg but not to ropivacaine 12 mg. Parturients in the bupivacaine group, however, experienced 
Comparison of the success rate in the different groups was based on the notion of`non-inferiority trials'. According to the recent International Conference of Harmonisation E9 Guidance Statistical Principles for Clinical Trials, ef®cacy of new treatment modalities is established by demonstrating superiority to placebo, by showing superiority to an active control or by demonstrating a dose±response relationship. These represent the so-called superiority' trials. Nevertheless, in clinical situations where the use of placebo is not applicable (for ethical or practical reasons) and where active treatment with established ef®cacy exists, active control trials designed to show that the ef®cacy of investigational products are not signi®cantly worse than that of the active drug that can be used (`noninferiority' trials). After having con®rmed non-inferiority, superiority of the alternative test treatment over reference treatment can additionally be tested without the need to adjust the signi®cance level. This method has been used for comparison of psychiatric, anaesthetic and oncological treatments.
11±13
In the present study, the dose of ropivacaine 12 mg was used for comparison with bupivacaine 8 mg. We chose a different dose because ropivacaine is not equipotent to bupivacaine after i.t. administration. 1 2 7 8 As revealed by our pilot study, the dose of 12 mg is the lowest dose of ropivacaine that produces anaesthesia comparable with bupivacaine 8 mg in parturients. Indeed, inadequate anaesthesia levels before surgery were recorded in 40 and 10% of patients having received, respectively, i.t. ropivacaine 8 and 10 mg with sufentanil 2.5 mg. Moreover, unsatisfactory pain relief during surgery was observed in 40% of patients who received these low doses of ropivacaine.
When considering the recent work performed by Khaw and colleagues 14 in similar clinical settings and using the same end-points, it is possible to get a precise idea of the local anaesthetic sparing effect of i.t. sufentanil. These authors studied the dose±response relationship for spinal ropivacaine alone. They were able to determine the ED 50 , ED 90 , and ED 95 to be 16.7, 24.5, and 26.8 mg, respectively. Taking our results into account, the addition of sufentanil 2.5 mg allows a reduction of nearly 50% of the dose of ropivacaine required for the ED 90 . Such sparing effect is in accordance with the data obtained by others for fentanyl. 5 6 Epidural ropivacaine has been regarded previously as having speci®c effects on sensitive nervous ®bres thereby producing less motor impairments than the other local anaesthetics. Using the i.t. route, however, this assumption is challenged by our results and by those of Khaw and colleagues 14 who clearly report an increasing proportion of patients developing full motor block with increasing dosage of ropivacaine.
It is interesting to consider the differences observed between bupivacaine and levobupivacaine. First, the success rate is in favour of the racemic mixture, levobupivacaine appearing to be less effective. Secondly, the duration of analgesia provided by the levovbupivacaine was signi®-cantly shorter. Thirdly, the motor block induced by the racemic mixture is characterized by a longer duration than the pure S(-)-enantiomer. This contrasts with previous reports comparing large doses of both local anaesthetics for epidural or brachial plexus anaesthesia and with two recent studies comparing the i.t. administration of hyperbaric solutions in human volunteers 15 and in patients undergoing hip replacement. 16 It is even more surprising knowing that levobupivacaine contains approximately 11% more active drug than the racemic mixture per millilitre. 17 The apparent equipotency of bupivacaine and levobupivacaine reported in these studies may be explained by the large dose of local anaesthetics used. The administration of supramaximal doses may have masked subtle potency differences. Recent work by Polley and colleagues 18 supports this hypothesis. These authors compared ropivacaine and levobupivacaine in advanced labour (cervical dilatation >7 cm). Taking into account the results of previous mean local anaesthetic concentration studies performed in early labour comparing bupivacaine vs ropivacaine 19 20 and bupivacaine vs levobupivacaine, 21 a 40% difference favouring levobupivacaine would have been expected. Yet surprisingly, in Polley's study, the two drugs have identical ED 50 . Our study, while con®rming the lower potency of levobupivacaine compared with bupivacaine, shows that the more invasive and sensitive the procedure, the more apparent the differences in ef®ciency between the drugs. Indeed, the quality of the pain relief needed during advanced labour or abdominal surgery with visceral traction appears to be very different from that of the pain relief required during early labour, knee arthroscopy, transurethral resection procedures, or simply testing in volunteers. 1 15 16 In this regard, it is interesting to note that some differences in the intensity of motor block have already been reported. 4 22 In conclusion, we have shown that the racemic mixture of bupivacaine combined with sufentanil remains an adequate choice when performing Caesarean sections under spinal anaesthesia. Moreover, as a result of the particular study design (strong surgical stimulus and submaximal doses) our data support a potency hierarchy amongst the long-acting local anaesthetics.
